John Woock - Jan 17, 2023 Form 4 Insider Report for Axonics, Inc. (AXNX)

Role: EVP, Chief Mktg/Strtgy Officer
Signature: /s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D
Stock symbol: AXNX
Transactions as of: Jan 17, 2023
Transactions value $: -$1,506,482
Form type: 4
Date filed: 1/19/2023, 07:07 PM
Previous filing: Sep 12, 2022
Next filing: Feb 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXNX	Common Stock	Options Exercise	$3.69K	+2.79K	+6.07%	$1.32^*	48.8K	Jan 17, 2023	Direct
transaction	AXNX	Common Stock	Sale	-$189K	-2.79K	-5.73%	$67.62	46K	Jan 17, 2023	Direct	F1
transaction	AXNX	Common Stock	Options Exercise	$537	+378	+0.82%	$1.42^*	46.4K	Jan 17, 2023	Direct
transaction	AXNX	Common Stock	Sale	-$25.5K	-378	-0.82%	$67.51	46K	Jan 17, 2023	Direct	F1
transaction	AXNX	Common Stock	Options Exercise	$213K	+15K	+32.63%	$14.19^*	61K	Jan 17, 2023	Direct
transaction	AXNX	Common Stock	Sale	-$1.01M	-15K	-24.6%	$67.29	46K	Jan 17, 2023	Direct	F1
transaction	AXNX	Common Stock	Options Exercise	$311K	+12K	+26.2%	$25.82	58K	Jan 17, 2023	Direct
transaction	AXNX	Common Stock	Sale	-$811K	-12K	-20.76%	$67.32	46K	Jan 17, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXNX	Stock Options (Right to buy)	Options Exercise	$0	-12K	-77.08%	$0.00	3.58K	Jan 17, 2023	Common Stock	12K	$25.82	Direct	F2
transaction	AXNX	Stock Options (Right to buy)	Options Exercise	$0	-15K	-49.09%	$0.00	15.6K	Jan 17, 2023	Common Stock	15K	$14.19	Direct	F3
transaction	AXNX	Stock Options (Right to buy)	Options Exercise	$0	-378	-100%	$0.00^*	0	Jan 17, 2023	Common Stock	378	$1.42	Direct	F4
transaction	AXNX	Stock Options (Right to buy)	Options Exercise	$0	-2.79K	-100%	$0.00^*	0	Jan 17, 2023	Common Stock	2.79K	$1.32	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This transaction was executed in multiple trades at prices ranging from $67.17 to $67.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2	The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vested on December 12, 2020 and the remainder vest at a rate of 1/36th per month commencing on January 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F3	The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vested on January 30, 2020, and the remainder vest at a rate of 1/36th per month commencing on February 1, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F4	The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vested on August 25, 2018 and the remainder vest at a rate of 1/36th per month commencing on September 1, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
F5	The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vested on July 5, 2018 and the remainder vest at a rate of 1/36th per month commencing on August 1, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.